METHYL (2R)-2-((5-((2R)-3-METHOXY-3-OXO-2-((4-(2-OXO-1H-QUINOLIN-3-YL)PIPERIDINE-1-CARBONYL)AMINO)PROPYL)-7-METHYLINDAZOLE-1-CARBONYL)AMINO)-3-(7-METHYL-1H-INDAZOL-5-YL)PROPANOATE
UNII VJN7DLQ6WY
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl (2r)-2-((5-((2r)-3-methoxy-3-oxo-2-((4-(2-oxo-1h-quinolin-3-yl)piperidine-1-carbonyl)amino)propyl)-7-methylindazole-1-carbonyl)amino)-3-(7-methyl-1h-indazol-5-yl)propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VJN7DLQ6WY.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C40H42N8O7 QIWHXNNPXWAPNB-CZNDPXEESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl (2r)-2-((5-((2r)-3-methoxy-3-oxo-2-((4-(2-oxo-1h-quinolin-3-yl)piperidine-1-carbonyl)amino)propyl)-7-methylindazole-1-carbonyl)amino)-3-(7-methyl-1h-indazol-5-yl)propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.